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Abstract. Many antibacterial are already resistant, so new antibacterial is needed. Objective: 
The compounds of N'- (4-Fluorobenzylidene) -4-hydroxybenzohydrazide, and N' - (3-
Bromobenzylidene) -4-hydroxybenzohydrazide as antibacterial generally contain azometin        
(HN-N=CH-) and halogen groups. Before   the compounds to be synthesized were done 
docking molecule study, to predict its activity as antibacterial. The synthesis was carried out by 
microwave and identification of the results with FT-IR, MS, 1H-NMR, and 13C-NMR, 
docking molecule study with the Molegro Virtual Docker program, and antibacterial activity by 
diffusion method. The obtained compounds of N '- (4-Fluorobenzylidene) -4-
hydroxybenzohydrazide, and N' - (3-Bromobenzylidene) -4-hydroxybenzohydrazide 87%, and 
81% yield respectively. The results of docking molecule study obtained reranked score lower 
than the starting material (methyl 4-hydroxybenzoate). The compounds have antibacterial 
activity against Gram positive (Bacillus subtilis) and Gram negative (Escherichia coli). 
Conclusion: N '- (4-Fluorobenzylidene) -4-hydroxybenzohydrazide and N' - (3-
Bromobenzylidene) -4-hydroxybenzohydrazide have been synthesized, characterized and 
exhibited promised antibacterial. 
1. Introduction  
Infection is a disease that still affects many people in the world, both lower, middle and upper levels of 
society. According to the World Health Organization (WHO) infectious diseases are the second leading 
cause of death in the world [1]. Infection is a dominant disease in developing countries and many people 
suffer from microbial Enterobacteria from Escherichia, Salmonella, Shigella, Klebsiella. Pathogenic 
microbes that are resistant to certain antimicrobials are also growing, for example MRSA (Methicillin-
resistant Staphylococcus aureus), VRSA (Vancomycin-resistant Staphylococcus aureus) and ESBL 
(Extended spectrum beta-lactamase producers). 
Fatty acids are one of the most important components in the formation of microbial cell walls, an 
important component of the composition of lipopolysaccharides and phospholipids in cell membranes. The 
pathway of fatty acid biosynthesis in microbes begins with acetylcholine. Fatty acid biosynthesis in bacteria 
through many stages and involves many enzymes. In the terminal stage there is a change in trans 2-enoyl 
ACP to acyl ACP which is affected by the enzyme enoyl-ACP reductase (ENR). Acyl ACP is needed as a 
phospholipid biosynthesis material, which is a constituent component of membranes in the microbial cell 
wall [2]. 
 Antimicrobials that selectively inhibit the function of cell membranes through resistance to ENR 
enzymes, both against Gram negative (E. coli), Gram positive Staphylococcus aureus (S. aureus), B subtilis 
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are nifuroxazida (N '- ( (5-nitrofuran-2-il) methylene) -4-hydroxybenzohidrazide). These compounds have 
hydroxyl groups on the benzene ring and azometin groups and are known as intestinal antiseptics [3]. 
 Hydrazide derivative compounds are widely used because they have biological activity and clinical 
applications that vary among them as antimicrobials [4]. The presence of hydroxyl on the benzene and 
azometin (-NN-N = CH-) as pharmacophore provide activity as antimicrobials [5]. In some antimicrobial 
structures, there is a hydroxyl group or an azometin group (-HN-N = CH-) which is a pharmacophore. In 
some compounds, these groups are in aromatic rings, aromatic heterocyclic rings or in nonaromatic 
heterocyclics, as –NH- or -N = C- [6]. 
Based on the description above, it was determined that the lead compound in this study was N-
benzilidene-4-hydroxybenzohidrazide. Substituted N-benzilidene-4-hydroxybenzohydrazide compounds 
synthesized based on ligand-based design molecular modeling using the Mollegro Virtual Docker (MVD) 
version 5.0 program. In molecular modeling, several derivatives of N-benzilidene-4-
hydroxybenzohidrazide are used as ligands, whereas as receptors, ENR is used (pdb.1C14) [7]. The 
structure of 1C14 is chosen because it is a target of compounds that have a working mechanism to inhibit 
ENR. 
The methyl 4-hydroxybenzoate is a generally limited antimicrobial compound that used as a food 
preservative and cosmetics. Modified the structure of methyl 4-hydroxybenzoate to 4-
hydroxybenzohydrazide, then modified to 4-hydroxybenzohydrazide-derived novel compounds. The 
compounds of 4-hydroxybenzohydrazide derivatives with some additional specific groups acting as 
chromophore such as the azometin group (-N-N = C-) and halogen (F, Br) groups, are expected to act as 
more antimicrobials and smaller toxicities [8]. The addition of groups also causes 4-
hydroxybenzohydrazide derivatives to become more lipophyllable, so that the ability to penetrate cell 
membranes also increases. Based on these descriptions, the synthesis of N’-(4-fluorobenzylidene)-4-
hydroxybenzohydrazide and N’-(3-bromobenzylidene)-4-hydroxybenzo hydrazide, indicated in vitro 
indispensable antibacterial effect.  
The antibacterial activity was performed on Gram negative (E. coli) and Gram positive (B. subtilis) to 
obtain minimum inhibitory concentration (MIC) of the compounds. Based on the background briefly above, 
the problems formulated in this study were: (1) Whether N’-(4-fluorobenzylidene)-4-
hydroxybenzohydrazide and N’-(3-bromobenzylidene)-4-hydroxybenzo hydrazide may be synthesized?  (2) 
How is their antimicrobial activity in these derivatives? This research will be informed new technology of 
the reaction method with microwave irradiation to synthesize of N’-benzylidene-4-hydroxybenzohydrazide 
derivatives (Figure 1).  
 
Figure 1.  Synthesis reaction of N’-benzylidene-4-hydroxybenzohydrazide derivatives 
      
2. Materials and Methods  
2.1 Synthesis of 4- hydroxybenzohydrazide  
The methyl 4-hydroxybenzoate (5 mmol) was added hydrazine hydrate (50 mmol) in the flask. The 
mixture of this compound was stirred until a homogeneous solution obtained and then it was irradiated 
with microwave. The mixture was cooled, added aquadest, washed with ethanol, filtered and 
recrystallized with ethanol.  The purity of compounds was tested by melting point and thin layer 
chromatography. Identification of compounds was performed using UV-VIS, FT-IR, 1H-NMR 
spectroscopy [9,10,11]. 
 
2.2 Synthesis of N’-benzylidene-4-hydroxybenzohydrazide derivatives  
4-Hydoxybenzohydrazide (5 mmol) and 4-fluorobenzaldehyde/3-bromobenzaldehyde (7 mmol) were 
mixture in the flask. The mixture was stirred until a homogeneous. The mixed solution was irradiated 
with microwave. The mixture was cooled to room temperature and then added aquadest, washed with 
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ethanol, and filtered. Crystals were recrystallized with ethanol.  The purity of compounds was tested 
by melting point and thin layer chromatography. Identification of compounds was performed using 
UV-VIS, FT-IR, MS, 1H-NMR, 13C-NMR spectroscopy [9,10,11]. 
 
3.Result and Discussion 
Synthesis of compounds was done by two step reactions, (1) Synthesis 4-hydroxybenzohydrazide and 
(2) Synthesis N’-benzylidene-4-hydroxybenzohydrazide derivatives. Synthesis of 4-
hydroxybenzohydrazide was done by the nucleophilic substitution reaction [12,13]. The 4-
Hydroxybenzohydrazide is obtained as a white needle crystalline, with 91% yield. The thin-layer 
chromatogram showed one spot with UV detector. The melting point of the compound was 255-256oC. 
Characterization of 4-hydroxybenzohydrazide was done with UV-Vis, FT-IR, 1H-NMR spectroscopy. 
Synthesis of N’-benzylidene-4-hydroxybenzohydrazide derivatives on second step reactions were done 
by the nucleophilic addition reaction [12,13] The N’-(4-fluorobenzylidene)-4-hydroxybenzohydrazide 
is white needle crystalline with synthesized percentage 87%. The thin-layer chromatogram showed 
one spot, m.p 245-246oC. Identification of N’-(4-fluorobenzylidene)-4-hydroxybenzohydrazide was 
done by UV-VIS, Infrared, MS, 1H-NMR and 13C-NMR spectroscopy. N’-(3-bromobenzylidene)-4-
hydroxybenzohydrazide is white needle crystalline with synthesized percentage 81%. The thin layer 
chromatogram showed one spot, m.p.  250-251oC.  
Characterization of 4-hydroxybenzohydrazide. The yield 91%, a white needle-shaped crystal; m.p. 
255-256oC; UV-Vis (EtOH), nm: 208 and 254. IR (KBr in cm-1): 1674 (-C=O amide), 3318 (-OH 
phenolic), 1590 and 1467 (-C=C- aromatic), 1354 (C-N), 3005 (Csp2-H), 850 (para di-substitution on 
benzene), 3197 (-NH2). 1H-NMR (DMSO-d6, ppm): 6.73 (dd, J=8.4 Hz, 2H, C6H4-), 7.64 (dd, J=9.2 
Hz, 2H, C6H4-), 9.89 (s, 1H, OH),9.44 (s, 1H, NH), 4.32 (s, 2H, NH2) [14,15].  
Characterization of N'-(4-fluorobenzylidene)-4-hydroxybenzohydrazide. The yield 87%, a white 
needle-shaped crystal; m.p. 245-246oC; UV-Vis (EtOH), nm: 224, and 306. IR (KBr in cm-1): 1629 (-
C=O amide), 3436 (-OH phenolic), 1599 and 1472 (-C=C- aromatic), 1367 (C-N), 3038 (Csp2-H), 848 
(para substitution of benzene), 758 (orto substitution of benzene), 3261 (-NH- stretching) and 1606 (-
NH- bending).  [M+Na] =281,0698. 1H-NMR (400MHz, DMSO-d6, ppm): 11.62 (s, 1H, -HC=N), 
10.08 (s, 1H, -NH-), 8.39 (s, 1H, OH), 6.83 (d, J=8.8 Hz, 2H from benzene), 7.26 (t, J =8 Hz, 2H from 
benzene), 7.79-7.71 (m, 4H from benzene). 13C-NMR (400MHz, DMSO-d6, ppm): 164.7 (=C-F), 
163.3(1C, C=O), 161.2 (1C, Csp2-OH), 146.2 (1C, -CH=N), 131.7, 131.2, 130.2, 129.6, 124.4, 116.5 
(2C), 116.3 (2C), 115.6 (10C from two aromatic rings) [14,15]. 
 
 
(a)                                             (b) 
Figure 2. Hydrogen bonding (a) and steric interaction (b) of N'-(4-fluorobenzylidene)-4-
hydroxybenzohydrazide with pdb.1C14 (2D) 
 
Characterization of N'-(3-bromobenzylidene)-4-hydroxybenzohydrazide. The yield 81%, a white 
needle-shaped crystal; m.p. 250-251oC; UV-Vis (EtOH), nm: 208, 226 and 306. IR (KBr in cm-1): 
1624 (-C=O amide), 3458 (-OH phenolic), 1591 and 1474 (-C=C- aromatic), 1429 (C-N), 847 (para 
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substitution of benzene), 3236 (-NH- stretching) and 1606 (-NH- bending). [M+Na] =340,9896 (99%), 
[M+Na] +2=342.9896 (100%). 1H-NMR (400MHz,DMSO-d6, ppm): 11.76 (s, 1H, HC=N-), 10.10 (s, 
1H, -NH-), 8.36 (s, 1H, OH), 6.85 (d, J=6.8 Hz, 2H from benzene), 7.34 (t, J=7.6 Hz, 1H from 
benzene), 7.54 (d, J=7.6 Hz, 1H from benzene), 7.80 (d, J=8.8 Hz, 1H from benzene), 7.86 (s, 1H from 
benzene). 13C-NMR (400 MHz, DMSO-d6, ppm): 163.3 (1C, C=O), 161.4 (1C, Csp2-OH), 145.6 
(1C, -CH=N), 137.5, 132.9, 131.4, 130.3, 129.5 (2C), 126.6, 124.2, 122.7, 115.6 (2C) (11C from two 
aromatic rings) [14,15]. 
    
                                                       (a)                                                (b) 
Figure 3. Hydrogen bonding (a) and steric interaction (b) of N'-(3-bromobenzylidene)-4-
hydroxybenzohydrazide with pdb.1C14 (2D) 
 
                                                       (a)                                                            (b) 
Figure 4. Hydrogen bonding (a) and steric interaction (b) of Methyl 4-hydroxybenzoate with 
pdb.1C14 (2D) 
 
The active crystal structure of 1C14 interacted with pharmacophores of compounds [Figure 3-5]. 
The structure of the ENR inhibitor (pdb. 1C14) was obtained from www.rcsb.org.  The rerank score of 
compounds based on molecular docking with receptor pdb. 1C14 program MVD (Molegro Virtual 
Docker 5.0) is smaller than the rerank score of methyl 4-hydroxybenzoate. This indicated that the 
modified compound has smaller bond energy, so that the binding is more stable [16,17]. The modified 
compounds be expected to have greater biological activity by docking molecule study. The rerank 
score of the compounds and the amino acids involved in the interaction [Table 1] which represents as 
ligand-protein binding energy.  
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                                                       (a)                                                           (b) 
Figure 5. Hydrogen bonding (a) and steric interaction (b) of Nifuroxazide with pdb.1C14 (2D) 
 
Table  1. Molecular docking results of N'-(4fluorobenzylidene)-4-hydroxybenzohydrazide, N'-(3-
bromo benzylidene)-4-hydroxybenzohydrazide, nifuroxazide and methyl 4-hydroxybenzoate with 
pdb. 1C14 program MVD 5.0 
 
Compounds Rerank Score 
(kcal/mol) 
Amino Acid Hydrogen 
Bonding 
Interaction 
steric (Van 
der waals) 
Methyl 4-
hydroxybenzoa
te 
-62.5223 Asp 1064, Val 1065, Cys 
1063, Gln 1040, Ile1092 
2 5 
Nifuroxazide -98.5737 Asp 1064, Val 1065, Ser 1070, 
Ala 1066, Cys 1063, Ile 1119 
4 6 
N'-4-
Fluorobenzylid
ene-4-
hydroxybenzoh
ydrazide 
-87.5696 Asp 1064, Val 1065, Thr 
1038, Gln 1040, Cys 1063, Ile 
1119, Ala 1066, Glu 1067 
2 8 
N'-(3-
Bromobenzylid
ene)-4-
hydroxybenzoh
ydrazide 
-89.5923 Asp 1064, Val 1065, Thr 
1038, Gln 1040, Cys 1063, Ile 
1119, Ala 1066, Glu 1067 
2 8 
 
 The lowest energy (RS) should represent the best-found binding mode. N’-benzylidene-4-
hydroxybenzohydrazide derivatives have a better rerank score (RS=-87.5696 and -89.5923 kcal/mol) 
than methyl 4-hydroxybenzoate (RS= -62.5223 kcal/mol) which indicate high affinity of the 
compounds against 1C14. Besides hydrogen bonds, there are steric interaction performed by 
compounds (methyl 4-hydroxybenzoate, N'-(4-fluorobenzylidene)-4-hydroxybenzohydrazide and N'-
(3-bromobenzylidene)-4-hydroxybenzohydrazide) with the sum of amino acid residues:  Asp 1064, 
Val 1065, and Cys 1063. Nifuroxazide as an intestinal antiseptic, in molecular docking has hydrogen 
bonds involving 4 kinds of amino acids (ie Asp 1064, Val 1065, Ser 1070, Ala 1066). Whereas in N '- 
(4-fluorobenzylidene) -4-hydroxybenzohydrazide and N' - (3-bromobenzylidene) -4-
hydroxybenzohydrazide hydrogen bonds only with two kinds of amino acids. N'-(4-
fluorobenzylidene)-4-hydroxybenzohydrazide and N'-(3-bromobenzylidene)-4-hydroxybenzo 
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hydrazide have an interaction with the amino acid residue of the 1C14 receptor, which is almost the 
same. 
The antibacterial activity of testing compounds against Bacillus subtilis FNCC 0059 and 
Escherichia coli ATCC 25922. Used nifuroxazide as reference standards. The antibacterial activity of 
target compounds was carried out by well diffusion method [17].  The N'-(4-fluorobenzylidene)-4-
hydroxybenzohydrazide has MIC 15.7 ppm against B. subtilis and E. coli respectively. The MIC of N'-
(3-bromobenzylidene)-4-hydroxybenzohydrazide against E. coli was 15.7 ppm, and 15.7 ppm against 
B. subtilis. The antibacterial activity of the compounds was detected because of the halogen and 
hydroxyl on benzene (-C6H4-X) [18] and azometin groups (-HN-N=CH-) [19, 20, 21]. Based on a 
docking molecule study, N'-(4-fluoro benzylidene)-4-hydroxybenzohydrazide) and N'-(3-
bromobenzylidene)-4-hydroxybenzohydrazide have the rerank score value lower than methyl 4-
hydroxybenzoate.  This is in accordance with the results of antibacterial tests on E. coli and B. subtilis. 
These compounds have a higher activity than methyl 4-hydroxybenzoate 
 
4.Conclusion  
The yields of N'-(4-fluorobenzylidene)-4-hydroxybenzohydrazide and N'-(3-bromobenzylidene)-4-
hydroxybenzohydrazide were obtained 87%, 81% respectively. (N'-(3-bromobenzylidene)-4-
hydroxybenzohydrazide). N '- (4-Fluorobenzylidene) -4-hydroxybenzohydrazide and N' - (3-
Bromobenzylidene) -4-hydroxybenzohydrazide have been exhibited promised antibacterial. 
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